No Picture
News

Tocagen and NRG Oncology to Collaborate on a Phase 2/3 Trial of Toca 511 & Toca FC in Newly Diagnosed Glioblastoma

Proposed NRG-BN006 Phase 2/3 trial to begin enrollment in 2019

SAN DIEGO, Nov. 29, 2018 /PRNewswire/ — Tocagen Inc. (Nasdaq: TOCA), a late clinical-stage, cancer-selective gene therapy company and NRG Oncology, a member of the National Cancer Instit… […]

No Picture
News

Ajinomoto Bio-Pharma Services Introduces AJICAP Bioconjugation Technology for ADC Manufacturing

SAN DIEGO, Nov. 28, 2018 /PRNewswire/ — Ajinomoto Bio-Pharma Services (“Aji Bio-Pharma”), a leading provider of biopharmaceutical contract development and manufacturing services, presented data at the World ADC Summit in San Diego this month descri… […]

No Picture
News

Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

DEPArray Technology Used for Detection and Isolation of Lymphoma and Multiple Myeloma Cells

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Nov. 27, 2018 /PRNewswire/ — Menarini Silicon Biosystems announced today that new hem-oncology research utilizing … […]

No Picture
News

Aethlon Medical’s Cancer Therapy Receives “Breakthrough Device” Designation from the U.S. Food and Drug Administration

SAN DIEGO, Nov. 27, 2018 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a “Breakthrough Device” designation from the U.S. Food and … […]

No Picture
News

Aethlon Medical’s Cancer Therapy Receives “Breakthrough Device” Designation from the U.S. Food and Drug Administration

SAN DIEGO, Nov. 27, 2018 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health, announced today that it has received a “Breakthrough Device” designation from the U.S. Food and … […]

No Picture
News

Mesa Biotech Receives FDA 510(k) Clearance and CLIA Waiver for Its Accula(TM) RSV Molecular Point of Care Test

Accula RSV Test FDA Cleared for Both Children and Adults

SAN DIEGO, Nov. 27, 2018 /PRNewswire/ — Mesa Biotech Inc., is a privately held, molecular diagnostic company that has developed an affordable and easy to operate PCR (polymerase chain reaction… […]

No Picture
News

Arena Pharmaceuticals Expands Senior Management Team to Support Commercialization and Medical Affairs

SAN DIEGO, Nov. 26, 2018 /PRNewswire/ — Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today announced the appointments of Robert Lisicki as Executive Vice President and Chief Commercial Officer, and Paul K. Audhya, MD, MBA, as Senior Vice President, M… […]